Colchicine in Periprocedural Myocardial Infarction: the Role of Alpha Defensin
NCT ID: NCT03735134
Last Updated: 2018-11-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
180 participants
INTERVENTIONAL
2018-11-30
2020-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Colchicine on Coronary Reperfusion in Patients With Acute Coronary Syndrome
NCT05472337
Colchicine for Reduction of Periprocedural Myocardial Injury in Percutaneous Coronary Intervention
NCT05745818
The Role of Colchicine in Reducing The Rate of Myocardial Reperfusion Injury
NCT05734612
The Use of Statins for Myocardial Death Prevention
NCT00772564
Procedure and In-hospital Outcome of Patients Under 40 Years Old Undergoing Primary Percutaneous Coronary Intervention for Acute ST Elevated Myocardial Infarction in Assiut University
NCT03266328
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control Group
Stable coronary artery disease patients who have been assigned to elective PCI and who will be given standard of care treatment
Standard of care treatment prior to elective PCI
All medications normally given to patients prior to elective PCI
Early colchicine loading dose
Stable coronary artery disease patients who have been assigned to elective PCI and who will be given standard of care treatment plus colchicine loading dose 12-24 hours before PCI
Colchicine Loading Dose
Two milligrams of colchicine will be administrated in addition to the standard of care treatment
Late colchicine loading dose
Stable coronary artery disease patients who have been assigned to elective PCI and who will be given standard of care treatment plus colchicine loading dose one hour prior to PCI
Colchicine Loading Dose
Two milligrams of colchicine will be administrated in addition to the standard of care treatment
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Colchicine Loading Dose
Two milligrams of colchicine will be administrated in addition to the standard of care treatment
Standard of care treatment prior to elective PCI
All medications normally given to patients prior to elective PCI
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Significant liver dysfunction
* Severe left ventricular dysfunction
* Severe low weight
* Chronic colchicine treatment
18 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hillel Yaffe Medical Center
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hille Yaffe Medical Center
Hadera, , Israel
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HYMC-99-18
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.